Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.68, No.1, p.200–207, 2021 |
||
Title: Long-term clinical benefit of Peg-IFNα and NAs sequential anti-viral therapy on HBV related HCC | ||
Author: Wen-Qian Qi, Qian Zhang, Xu Wang, Yan Xu, Ping Zhao, Hong-Hua Guo, Chang-Yu Zhou, Yu Sun, Lin Liu, Jiang-Bin Wang | ||
Abstract: Analysis of the value of long-term anti-viral therapy using sequential Peg-IFN therapy and nucleos(t)ide analogues (NAs) improves the prognosis of HBV-related HCC. HBV-related HCC patients were classified into sequential therapy with Peg-IFNα-2a and NAs, and NAs therapy alone. All patients were followed up for 5 years. The survival rate, HCC recurrence rate, Child Pugh score, and side effects of drugs were evaluated. Firstly, the early and late cumulative survival rate was higher in patients receiving antiviral therapy compared with the control patients (P < 0.05). Patients receiving sequential therapy with Peg-IFNα-2a and NAs showed a higher late cumulative survival rate and significantly reduced early and late recurrence rate, compared to those in the NA-alone group (P < 0.05). Single NAs therapy only reduced the late recurrence rate in HCC-patients. Secondly, NAs therapy significantly increased the Child Pugh score after five years of therapy (five-year therapy 7.03 ± 1.50 vs. initial score 6.63 ± 0.85; P 0.05). Compared to the control patients, patients receiving anti-viral therapy (NAs alone or sequential therapy with Peg-IFNα-2a and NAs) exhibited a significantly decreased Child Pugh score (P recurrence rate in patients. |
||
Keywords: primary hepatocellular carcinoma; Peg-IFN; nucleos(t)ide analogues; antiviral therapy | ||
Published online: 17-Sep-2020 | ||
Year: 2021, Volume: 68, Issue: 1 | Page From: 200, Page To: 207 | |
doi:10.4149/neo_2020_200506N493 |
||
|
download file |
|